Adaptive Biotechnologies CorporationADPTNASDAQ
LOADING
|||
Operating Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
141.10%
↑ 230808% above average
Average (30q)
-0.06%
Historical baseline
Range
High:141.10%
Low:-54.39%
Volatility
-319644.1%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 141.10% |
| Q2 2025 | 15.43% |
| Q1 2025 | 12.51% |
| Q4 2024 | -3.69% |
| Q3 2024 | 31.04% |
| Q2 2024 | 2.96% |
| Q1 2024 | 31.39% |
| Q4 2023 | -39.47% |
| Q3 2023 | -6.56% |
| Q2 2023 | 16.39% |
| Q1 2023 | -45.95% |
| Q4 2022 | 13.75% |
| Q3 2022 | 13.47% |
| Q2 2022 | 16.75% |
| Q1 2022 | -2.39% |
| Q4 2021 | -9.36% |
| Q3 2021 | -13.18% |
| Q2 2021 | -20.55% |
| Q1 2021 | 6.69% |
| Q4 2020 | -19.41% |
| Q3 2020 | -0.38% |
| Q2 2020 | -6.61% |
| Q1 2020 | -43.13% |
| Q4 2019 | -33.98% |
| Q3 2019 | -12.10% |
| Q2 2019 | 19.66% |
| Q1 2019 | -41.72% |
| Q4 2018 | -54.39% |
| Q3 2018 | 31.19% |
| Q2 2018 | -1.33% |
| Q1 2018 | 0.00% |